Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -47.117\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a [Cl-].[NH3+]CCCn1c(C(=O)c2ccc(Cl)cc2)c2ccc([N+](=O)[O-])cc2[n+]1[O-]
b COc1ccccc1N(CC(=O)NC1CCCC1)C(=O)CNC(=O)c1cccs1
c O=C(NC(=S)Nc1ccc(N2CCOCC2)cc1)c1ccco1
d C/C(CC(=O)Nc1cccnc1)=N\NC(=O)c1ccc([N+](=O)[O-])c(Cl)c1
Answer: a. [Cl-].[NH3+]CCCn1c(C(=O)c2ccc(Cl)cc2)c2ccc([N+](=O)[O-])cc2[n+]1[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
[Cl-].[NH3+]CCCn1c(C(=O)c2ccc(Cl)cc2)c2ccc([N+](=O)[O-])cc2[n+]1[O-]
[Cl-].[NH3+]CCCn1c(C(=O)c2ccc(Cl)cc2)c2ccc([N+](=O)[O-])cc2[n+]1[O-]
3-[3-(4-chlorobenzoyl)-6-nitro-1-oxidoindazol-1-ium-2-yl]propylazanium;chloride